Increased spontaneous apoptosis in T lymphocytes in DiGeorge anomaly

Clinical and Experimental Immunology

Volumn 113, Issue 1, 1998, Pages 65-71

  Gupta, S ^a,b   Aggarwal, S ^a   Nguyen, T ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Apoptosis; DiGeorge syndrome; T cell subsets; Thymic aplasia

Indexed keywords

DNA FRAGMENT; FAS ANTIGEN; MESSENGER RNA; MONOCLONAL ANTIBODY; PROPIDIUM IODIDE; PROTEIN BCL 2; THYMOSIN ALPHA1;

APOPTOSIS; ARTICLE; CASE REPORT; CONTROLLED STUDY; DIGEORGE SYNDROME; FEMALE; FLOW CYTOMETRY; GEL ELECTROPHORESIS; HUMAN; HUMAN CELL; MONONUCLEAR CELL; PERIPHERAL LYMPHOCYTE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE;

ADOLESCENT; ANTIGENS, CD95; APOPTOSIS; BCL-X PROTEIN; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 22; DIGEORGE SYNDROME; FAS LIGAND PROTEIN; FEMALE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; INFANT; MEMBRANE GLYCOPROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; RNA, MESSENGER; T-LYMPHOCYTE SUBSETS;

EID: 0031816589     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1998.00629.x     Document Type: Article

References (32)

1. Hong R. The DiGeorge anomaly. In: Rosen FS, Seligmann M, eds. Immunodeficiencies. Chur: Harwood Academic Publications, 1993: 167-76.
2. Muller W, Kallfels HC, Franz A, Rieger CHL. The DiGeorge syndrome. II. Immunological findings in partial and complete form of the disorder. Eur J Pediatr 1989; 149:96-103.
3. Iwata T, Incefy GS, Cunningham-Rundles S, Cunningham-Rundles C, Smithwick E, Geller N, O'Reilly R, Good RA. Circulating thymic hormone activity in patients with primary and secondary immunodeficiency diseases. Am J Med 1981; 71:385-94.
4. Wara DW, Matin NL, Wara WM, Goldstein AL, McClure JE. Thymosin-alpha 1 levels in children with primary cellular immunodeficiency and in adults with malignancy. In: Serrou B, Rosenfeld C, Daniels JC, Saunders JP, eds. Current concepts in human immunology and cancer immunomodulation. Amsterdam: Elsevier, 1982:559-66.
5. Carey AH, Kelly D, Halford S et al. Molecular genetic study of the frequency of monosomy 22q11 in DiGeorge syndrome. Am J Hum Genet 1992; 51:964-70.
6. Gupta S. Apoptosis/programmed cell death. A historic perspective. Adv Exp Med Biol 1996; 402:1-9.
7. Wyllie AH, Kerr JFR, Currie AR. Cell death: the significance of apoptosis. Int Rev Cytol 1980; 68:251-306.
8. Osborne BA. Apoptosis and the maintenance of homeostasis in the immune system. Curr Opin Immunol 1996; 8:245-54.
9. Mountz JD, Zhou T, Wu J, Wang W, Su X, Cheng J. Regulation of apoptosis in immune cells. J Clin Immunol 1995; 15:1-16.
10. Nagata S. Apoptosis: telling cells their time is up. Current Biol 1997; 10:1241-3.
11. Cohen JJ. Apoptosis and its regulation. Adv Exp Med Biol 1996; 406:11-20.
12. Reed JC. Bcl-2 and the regulation of programmed cell death. J Cell Biol 1994; 124:1-6.
13. Nagata S, Golstein P. The Fas death factor. Science 1995; 267:1499-56.
14. Suda T, Nagata S. Purification and characterization of lhe FasL that induces apoptosis. J Exp Med 1994; 179:873-9.
15. Dhein J, Danier PT, Traub BC, Oehm A, Moller P, Krammer PH. Induction of apoptosis by monoclonal antibody anti-APO-1 class switch variants is dependent on cross-linking of APO-1 cell surface antigen. J Immunol 1992; 149:3166-73.
16. Nunez G, Merino R, Simonian PL, Grilott DA. Regulation of lymphoid apoptosis by Bcl-2 and Bcl-x. Adv Exp Med Biol 1996; 406:75-82.
17. Itoh N, Tsujimoto Y, Nagata S. Effect of Bcl-2 on Fas-antigen-mediated cell death. J Immunol 1993; 151:621-7.
18. Iwai K, Miyawaki T, Takizawa T, Konno A, Ohta K, Yachi A, Seki H, Taniguchi N. Differential expression of bcl-2 and susceptibility to anti-Fas-mediated cell death in peripheral blood lymphocytes, monocytes, and neutrophils. Blood 1994; 84:1201-8.
19. Boise LH, Gonzalez-Garcia M, Postema CE et al. bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic death. Cell 1993; 74:597-608.
20. Wesselborg S, Janssen O, Kabelitz D. Induction of activation-driven death (apoptosis) in activated but not resting peripheral blood T cells. J Immunol 1993; 150:4338-45.
21. Alderson MR, Tough TW, Davis-Smith T et al. Fas ligand mediates activation-induced cell death in human T lymphocytes. J Exp Med 1995; 181:71-77.
22. Ju ST, Panka DJ, Cui H et al. (CD95)/FasL interactions required for programmed cell death after T cell activation. Nature 1995; 373:444-8.
23. Yoshino T, Kondo E, Cao L, Takahashi K, Hayashi K, Nomura S, Akagi T. Inverse expression of bcl-2 protein and Fas antigen in lymphoblasts in peripheral lymph nodes and activated peripheral blood T and B lymphocytes. Blood 1994; 83:1856-61.
24. Suda T, Okazaki T, Naito T et al. Expression of the Fas ligand in cells of T cell lineage. J Immunol 1995; 154:3806-13.
25. Tanaka M, Suda T, Takahashi T, Nagata S. Expression of the functional soluble form of human Fas ligand in activated lymphocytes. EMBO J 1995; 14:1129-35.
26. Tanaka M, Suda T, Haze K et al. Fas ligand in human serum. Nat Med 1996; 2:317-22.
27. Dhein J, Walczak H, Bäumler C, Debatin KM, Krammer PH. Autocrine T-cell suicide mediated by APO-1/(Fas/CD95). Nature 1995; 373:438-41.
28. Suda T, Tanaka M, Miwa K, Nagata S. Apoptosis of mouse naive T cells induced by recombinant soluble Fax ligand and activation-induced resistance to Fas ligand. J Immunol 1996; 157:3918-24.
29. Zipp F, Martin R, Lichtenfels R, Roth W, Dichgans J, Kramer PH, Weller M. Human autoreactive and foreign antigen-specific T cells resist apoptosis induced by soluble recombinant CD95 ligands. J Immunol 1997; 159:2108-15.
30. Nishimura Y, Ishii A, Kobayashi Y, Yamasaki Y, Yonehara S. Expression and function of mouse Fas antigen on immature and mature T cells. J Immunol 1995; 154:4395-403.
31. + thymocytes by the anti-Fas antibody. J Exp Med 1995; 181:485-91.
32. McCormack JE, Callahan JE, Kappler J, Marrack PC. Profound deletion of mature T cells in vivo by chronic exposure to exogenous superantigen. J Exp Med 1993; 150:3785-92.